As autoreactive pro-inflammatory CD4+ T lymphocytes are key players in the onset and the development of the disease [51,52], it seemed rational and valuable to assess the effect of the ABP dendrimer in an animal model of MS insofar as it is able to inhibit the proliferation of CD4+ T lymphocytes [35]. Here, CD4 is linked to myeloid sarcoma.